DrugPatentWatch Database Preview

NAVANE Drug Profile

« Back to Dashboard

When do Navane patents expire, and when can generic versions of Navane launch?

Navane is a drug marketed by Pfizer and is included in three NDAs.

The generic ingredient in NAVANE is thiothixene hydrochloride. There are six drug master file entries for this compound. Additional details are available on the thiothixene hydrochloride profile page.

Summary for NAVANE

US Patents:	0
Applicants:	1
NDAs:	3
Bulk Api Vendors:	31
Patent Applications:	3,089
Formulation / Manufacturing:	see details
DailyMed Link:	NAVANE at DailyMed

Synonyms for NAVANE

(9Z)-N,N-dimethyl-9-[3-(4-methylpiperazin-1-yl)propylidene]-9H-thioxanthene-2-sulfonamide

(9Z)-N,N-dimethyl-9-[3-(4-methylpiperazin-1-yl)propylidene]thioxanthene-2-sulfonamide

(E)-Thiothixene

(Z)-N,N-Dimethyl-9-(3-(4-methylpiperazin-1-yl)propylidene)-9H-thioxanthene-2-sulfonamide

(Z)-Thiothixene

{2-(Dimethylsulfamoyl)-[9-(4-methyl-1-piperazinyl)propylidene]thiox} anthene

2-(Dimethylsulfamoyl)-(9-(4-methyl-1-piperazinyl)propylidene)thioxanthene

3313-26-6

5591-45-7

7318FJ13YJ

9H-Thioxanthene-2-sulfonamide, N, {N-dimethyl-9-[3-(4-methyl-1-piperazinyl)propylidene]-,} (Z)-

9H-Thioxanthene-2-sulfonamide, N,N-dimethyl-9-[3-(4-methyl-1-piperazinyl)propylidene]-

AC1LJ0FG

AKOS015850761

AN-18958

AOB5787

AS-16925

BDBM78576

BIDD:PXR0153

CCG-205218

CHEBI:9571

CHEMBL1201

cid_941651

cis-N,N-Dimethyl-9-(3-(4-methyl-1-piperazinyl)propylidene)thioxanthene-2-sulfonamide

cis-Thiothixene

CP 12252-1

CP-12,252-1

CP-12,252-1 base

CPD000058396

CS-7959

D00374

DB01623

DTXSID2091542

GFBKORZTTCHDGY-UWVJOHFNSA-N

GTPL212

HMS2230F08

HY-108324

Lopac0_001144

LS-153666

LS-153667

MLS000028463

MLS006010662

N,N-Dimethyl-9-(3-(4-methyl-1-piperazinyl)propylidene)thiaxanthene-2-sulfonamide

N,N-Dimethyl-9-[3-(4-methyl-1-piperazinyl)propylidene]-9H-thioxanthene-2-sulfonamide #

Navan

Navane (TN)

Navaron

NCGC00162353-01

NSC-108165

NSC108165

Opera_ID_626

Orbinamon

P-4657-B

P-4657A

P-4657B

PDSP1_000038

PDSP1_000625

PDSP1_000626

PDSP2_000038

PDSP2_000622

SAM002589997

SCHEMBL34305

SMR000058396

T15560

thiothixene

Thiothixene (USP)

Thiothixene (Z)

Thiothixene [USAN]

Thiothixene hydrochloride

Thiothixene, meets USP testing specifications

Thiothixene, United States Pharmacopeia (USP) Reference Standard

Thiothixine

Thioxanthene-2-sulfonamide, N,N-dimethyl-9-(3-(4-methyl-1-piperazinyl)propylidene)-

Thioxanthene-2-sulfonamide, N,N-dimethyl-9-(3-(4-methyl-1-piperazinyl)propylidene)-, (E)-

Thioxanthene-2-sulfonamide, N,N-dimethyl-9-(3-(4-methyl-1-piperazinyl)propylidene)-, (Z)-

Tiotixene

Tiotixene (JAN)

Tiotixene [INN]

Tiotixeno

Tiotixeno [INN-Spanish]

Tiotixenum

Tiotixenum [INN-Latin]

trans-N,N-Dimethyl-9-(3-(4-methyl-piperazinyl)propylidene)thioxanthene-2-sulfonamide

UNII-7318FJ13YJ

UNII-LF886533UR component GFBKORZTTCHDGY-UWVJOHFNSA-N

ZINC30690433

US Patents and Regulatory Information for NAVANE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pfizer	NAVANE	thiothixene	CAPSULE;ORAL	016584-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No
Pfizer	NAVANE	thiothixene hydrochloride	INJECTABLE;INJECTION	016904-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Pfizer	NAVANE	thiothixene	CAPSULE;ORAL	016584-004	Approved Prior to Jan 1, 1982		DISCN	Yes	No
Pfizer	NAVANE	thiothixene hydrochloride	INJECTABLE;INJECTION	016904-002	Approved Prior to Jan 1, 1982		DISCN	No	No
Pfizer	NAVANE	thiothixene	CAPSULE;ORAL	016584-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No